A Comparative Study of Potassium-Competitive Acid Blocker (Vonoprazan) and Proton Pomp Inhibitors in Helicobacter Pylori Eradication Therapy.

Trial Profile

A Comparative Study of Potassium-Competitive Acid Blocker (Vonoprazan) and Proton Pomp Inhibitors in Helicobacter Pylori Eradication Therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jul 2016

At a glance

  • Drugs Vonoprazan (Primary)
  • Indications Duodenal ulcer; Gastric cancer; Gastric ulcer; Gastritis; Helicobacter pylori infections; MALT lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top